ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.
MaxCyte Inc

MaxCyte Inc (MXCT)

4.06
-0.04
(-0.98%)
Closed September 18 4:00PM
4.06
0.005
(0.12%)
After Hours: 5:30PM

Your Hub for Real-Time streaming quotes, Ideas and Live Discussions

Key stats and details

Current Price
4.06
Bid
4.05
Ask
4.65
Volume
277,370
3.99 Day's Range 4.25
2.45 52 Week Range 5.545
Market Cap
Previous Close
4.10
Open
4.07
Last Trade
1
@
4.06
Last Trade Time
Financial Volume
$ 1,137,262
VWAP
4.1002
Average Volume (3m)
431,110
Shares Outstanding
103,504,571
Dividend Yield
-
PE Ratio
-11.05
Earnings Per Share (EPS)
-0.37
Revenue
41.29M
Net Profit
-37.92M

About MaxCyte Inc

MaxCyte Inc operates in the United States healthcare sector. It develops proprietary electroporation technology, which used blood cells instead of traditional chemical methods to transport medical gene therapies to targeted sites, increasing their safety and efficacy. The company technology finds it... MaxCyte Inc operates in the United States healthcare sector. It develops proprietary electroporation technology, which used blood cells instead of traditional chemical methods to transport medical gene therapies to targeted sites, increasing their safety and efficacy. The company technology finds its use in biotechnology and pharmaceutical firms engaged in cell therapy, including gene editing and immuno-oncology and in drug discovery, development, and biomanufacturing. Its products include MaxCyte STX, VLX, and GT. The company application includes Cell/Gene Therapy, Protein Production, Cell-based Assays, Gene Editing, Cell Line Development, and Viral Vectors/Vaccines. It acquires its income principally from the sale or lease of instruments and processing assemblies. Show more

Sector
Biological Pds,ex Diagnstics
Industry
Biological Pds,ex Diagnstics
Website
Headquarters
Wilmington, Delaware, USA
Founded
-
MaxCyte Inc is listed in the Biological Pds,ex Diagnstics sector of the NASDAQ with ticker MXCT. The last closing price for MaxCyte was $4.10. Over the last year, MaxCyte shares have traded in a share price range of $ 2.45 to $ 5.545.

MaxCyte currently has 103,504,571 shares outstanding. The market capitalization of MaxCyte is $424.37 million. MaxCyte has a price to earnings ratio (PE ratio) of -11.05.

MXCT Latest News

MaxCyte Signs Strategic Platform License with Kamau Therapeutics to Accelerate the Development of Cell Therapies for Genetic Diseases

ROCKVILLE, Md. and SOUTH SAN FRANCISCO, Calif., Sept. 15, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (Nasdaq: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling...

MaxCyte to Participate in Virtual Craig-Hallum Capital Group Bioprocessing Conference

ROCKVILLE, Md., Sept. 05, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...

MaxCyte Reports Second Quarter and Half-Year 2024 Financial Results and Updates Full Year 2024 Guidance

ROCKVILLE, Md., Aug. 06, 2024 (GLOBE NEWSWIRE) -- MaxCyte, Inc., (NASDAQ: MXCT; LSE: MXCT), a leading, cell-engineering focused company providing enabling platform technologies to advance the...

PeriodChangeChange %OpenHighLowAvg. Daily VolVWAP
10.12.525252525253.964.2553.7952811254.0366032CS
4-0.14-3.333333333334.24.433.723182984.11995818CS
12004.065.1353.584311104.20173512CS
26-0.25-5.800464037124.315.263.574738114.28236766CS
520.6418.71345029243.425.5452.456714014.1598774CS
156-10.03-71.185237757314.09152.455890395.62972097CS
260-12.93-76.103590347316.9917.442.455910096.10024597CS

Movers

View all
  • Most Active
  • % Gainers
  • % Losers
SymbolPriceVol.
OMEXOdyssey Marine Exploration Inc
$ 1.39
(180.07%)
328.86M
PRTGPortage Biotech Inc
$ 9.7581
(115.41%)
51.53M
APLTApplied Therapeutics Inc
$ 7.86
(69.03%)
51.66M
XCHXCHG Ltd
$ 18.40
(65.77%)
1.26M
WBUYWeBuy Global Ltd
$ 0.1867
(60.95%)
247.93M
GLMDGalmed Pharmaceuticals Ltd
$ 6.83
(-54.77%)
6.24M
KAKineta Inc
$ 0.5691
(-31.35%)
530.74k
DTSSDatasea Inc
$ 2.07
(-29.59%)
1.34M
CBUSCibus Inc
$ 3.595
(-28.95%)
2.31M
BFIBurgerFi International Inc
$ 0.1705
(-26.98%)
16.55M
OMEXOdyssey Marine Exploration Inc
$ 1.39
(180.07%)
328.86M
NVDANVIDIA Corporation
$ 113.37
(-1.92%)
310.12M
WBUYWeBuy Global Ltd
$ 0.1867
(60.95%)
247.93M
SQQQProShares UltraPro Short QQQ
$ 8.40
(1.45%)
200.53M
LUNRIntuitive Machines Inc
$ 7.4512
(37.99%)
141.82M

Discussion

View Full Feed
johnydollar johnydollar 4 minutes ago
Well, are kramers a scam company.........


Don't take my word for it........

Look at this companies.....

The Securities and Exchange Commission announced today charges against Curt Kramer of Jericho, New York, and his wholly owned businesses Power
DBMM
Renee Renee 4 minutes ago
KA changed to KANT. Delisted from the Nasdaq to the OTC:

https://otce.finra.org/otce/dailyList?viewType=Additions
KA
JOHNNIEBG JOHNNIEBG 5 minutes ago
YEARS OF FIXING ALL OF THE PROBLEMS THAT TRUMP LEFT !!!!!
Renee Renee 6 minutes ago
Still on top of it.....but can only post when I get home from work.

So, SMFL delisted from the Nasdaq to the OTC again:

https://otce.finra.org/otce/dailyList?viewType=Additions
SMFL
JOHNNIEBG JOHNNIEBG 6 minutes ago
Read the whole article and maybe you will learn something !!!!!

https://www.nbcnews.com/business/economy/trump-inherited-booming-economy-handed-biden-nation-shambles-n1255033

The new president, on the other hand, faces a heavier lift. “President Trump is handing Biden a
janice shell janice shell 7 minutes ago
I wondered if it was that one. But I thought from what he said that it--Lee Pharmaceuticals, not RONN--was an SEC filer not so long ago. But it hasn't been one since 2005, when it filed a Form 15. And now it's doing, or has done, a Reg A offering.

So what S-1 is Cableguy talking abou
vinmantoo vinmantoo 7 minutes ago
Anybody want to guess when this will be resolved one way or another?

My guess is it will be on Oct 1st.

This guess isn't based on any insight or information. I like October because it has Halloween🎃 and my birthday.🎂
RVNC
Preciouslife1 Preciouslife1 7 minutes ago
Hi!! All MM Signaling of intent ...
CDMO
delerious1 delerious1 7 minutes ago
Whew...a little drama there ...but so sorry I don't do recipes
Hoskuld Hoskuld 7 minutes ago
You are kidding yourself if you think Dr. Jin is in charge of trial design. That is not in his job title or list of responsibilities. He contributes as a member of the team, no doubt, but he is not in charge. It is clear that you have never worked in biopharm and that is OK - but your musings are
AVXL
crazy horse 0 crazy horse 0 7 minutes ago
LOL be careful

https://truthsocial.com/@BabylonBee/113159975907557154
XMaster2023 XMaster2023 8 minutes ago
If no BP is interested, why are you here 24/7 posting diversionary comments? Bad stock, Bad Management, etc, etc, etc. Only one reason. To try and create a smoke screen so the market makers can drive the price down. If you’re not on the site, new investors will buy at these prices which are worth
NWBO
Investor082 Investor082 9 minutes ago
Of course.

Flip just confirmed that he does not expect any cash payout (forget about significant cash) and a big pharma to PR combo trial deal. Rather he expects a small company like Oncovir to be involved! ;)

It’s logical that there will be a major dilution to fund t
NWBO
FACT-MASTER FACT-MASTER 10 minutes ago
https://www.americanbulls.com/SignalPage.aspx?lang=en&Ticker=ESPR

Sheldon can't get'er done.
ESPR
Filterthenoise Filterthenoise 10 minutes ago
I think much sooner. Guess it depends if they take their foot off from cutting deals so they can get the backed up fins out.
RNVA
Lime Time Lime Time 10 minutes ago
This CEO should have used a RW to withdraw the original Form 15. That's what makes me interested here because he seems very disturbed of what to do. Very low float on Expert Market. I think the CEO is confused on what to do to make this trading again. These are the tickers that we need to target mod
OTCM
weedisgreen weedisgreen 10 minutes ago
Btw, hopefully weak hands as i have a nice buy order in around the 1st level of support!
TCNNF
DewDiligence DewDiligence 11 minutes ago
From the same PR: The partnership will initially seek to unlock $30 billion of private equity capital over time from investors, asset owners, and corporates, which in turn will mobilize up to $100 billion in total investment potential when including debt financing.$30B of equity financing is actual
crazy horse 0 crazy horse 0 11 minutes ago
Harris and TRUMP

https://www.facebook.com/reel/1426761734666269
demonsmith demonsmith 11 minutes ago
Everything a scam if your not in once you get in it not scam no more we know how u play
PHBI
Welcome2Pinkyland Welcome2Pinkyland 11 minutes ago
Otc trading is not for everybody - like scammybear - who tried- put the time in - and failed -only to be reduced to a useless Ihub basher troll clown- who instead of looking inward - rages against the otc and those who trade otc stocks.
sonofgodzilla sonofgodzilla 12 minutes ago
Exactly ProfitChaser, well said. I loved today’s volume and especially not seeing it spike violently. Heck, we even ended up a healthy plant- based GREEN! Excited for what’s to come in short order.

GL.

sog
BBUZ
weedisgreen weedisgreen 12 minutes ago
I agree with them and view it as not material to the big picture. Id be more interested why Kim sold shares.
TCNNF

Your Recent History

Delayed Upgrade Clock